Invicta Diagnostic Limited Expands Global Reach with U.S. Tele-Radiology Services
Invicta Diagnostic Limited has announced a major expansion of its service portfolio, confirming that it has begun offering tele-radiology services to clients in the United States. This strategic move signifies a significant advancement in the company's global growth trajectory, extending its diagnostic reporting capabilities beyond Indian borders.The launch of U.S. tele-radiology services reinforces the company's commitment to providing high-quality diagnostic reporting across international boundaries. Invicta Diagnostic Limited stated that this international addition aims to enhance patient care by ensuring timely and accurate reporting to a broader global healthcare network.
Product Launch Details
The new tele-radiology offering was formally launched on May 22, 2026, catering specifically to the international market. The details of the service launch are presented below:| Metric | Detail |
|---|---|
| Product Name | Tele-Radiology services |
| Launch Date | 22-05-2026 |
| Service Category | Diagnostic Services |
| Target Market | International Market |
| Launch Country | United States of America |
INVICTA Stock Price Movement
As of 12:52 PM, shares of Invicta Diagnostic Limited are slipping by 5.00% in live trading, currently finding support at ₹70.35. The stock is experiencing selling pressure, as evidenced by a trading volume of 9,600 shares in the live market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.